Treatment of hind limb ischemia using angiogenic peptide nanofibers

For a proangiogenic therapy to be successful, it must promote the development of mature vasculature for rapid reperfusion of ischemic tissue. Whole growth factor, stem cell, and gene therapies have yet to achieve the clinical success needed to become FDA-approved revascularization therapies. Herein,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Biomaterials
Huvudupphovsmän: Kumar, Vivek A., Liu, Qi, Wickremasinghe, Navindee C., Shi, Siyu, Cornwright, Toya T., Deng, Yuxiao, Azares, Alon, Moore, Amanda N., Acevedo-Jake, Amanda M., Agudo, Noel R., Pan, Su, Woodside, Darren G., Vanderslice, Peter, Willerson, James T., Dixon, Richard A., Hartgerink, Jeffrey D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4905688/
https://ncbi.nlm.nih.gov/pubmed/27182813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2016.04.032
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk